Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×

Purchasing is currently unavailable on Cambridge Core due to maintenance. We apologise for the inconvenience and are working to restore services.

  1. Home
  2. Journals
  3. Expert Reviews in Molecular Medicine
  4. Volume 3 Issue 19
Journal Home
Refine listing

Refine listing

Access:
Publication date:

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×
< Back to all volumes

Volume 3 - Issue 19 - 18 July 2001

Contents

Review Article

  • Chemokines in cancer

  • Mitchell J. Frederick, Gary L. Clayman
  • Published online by Cambridge University Press:
    12 February 2004, pp. 1-18

  • Chemokines are small, chemotactic cytokines that direct migration of leukocytes, activate inflammatory responses and participate in many other pleiotropic functions, including regulation of tumour growth. Chemokines modulate tumour behaviour by three important mechanisms: regulation of tumour-associated angiogenesis, activation of a host tumour-specific immunological response, and direct stimulation of tumour cell proliferation in an autocrine fashion. All of these mechanisms are promising points of cancer intervention, and preclinical mouse models suggest that chemokine antagonists and agonists could become important in the development of new anticancer therapies.